These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 3491051

  • 1. Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Röllinghoff M.
    Infect Immun; 1986 Dec; 54(3):909-12. PubMed ID: 3491051
    [Abstract] [Full Text] [Related]

  • 2. Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.
    Solbach W, Forberg K, Kammerer E, Bogdan C, Röllinghoff M.
    J Immunol; 1986 Jul 15; 137(2):702-7. PubMed ID: 3487578
    [Abstract] [Full Text] [Related]

  • 3. Leishmania major: analysis of lymphocyte and macrophage cellular phenotypes during infection of susceptible and resistant mice.
    Heinzel FP, Sadick MD, Locksley RM.
    Exp Parasitol; 1988 Apr 15; 65(2):258-68. PubMed ID: 3127233
    [Abstract] [Full Text] [Related]

  • 4. Macrophage activation for antileishmanial defense by an apparently novel mechanism.
    Wyler DJ, Beller DI, Sypek JP.
    J Immunol; 1987 Feb 15; 138(4):1246-9. PubMed ID: 3100630
    [Abstract] [Full Text] [Related]

  • 5. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
    Rostamian M, Jafari D, Abolghazi M, Farahani H, Niknam HM.
    Parasitol Res; 2018 Sep 15; 117(9):2949-2956. PubMed ID: 29978420
    [Abstract] [Full Text] [Related]

  • 6. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
    Müller I, Pedrazzini T, Kropf P, Louis J, Milon G.
    Int Immunol; 1991 Jun 15; 3(6):587-97. PubMed ID: 1909563
    [Abstract] [Full Text] [Related]

  • 7. Antigen recognition by effector T cells in antileishmanial defense.
    Sypek JP, Panosian CB, Wyler DJ.
    J Infect Dis; 1985 Nov 15; 152(5):1057-63. PubMed ID: 2413143
    [Abstract] [Full Text] [Related]

  • 8. Viscerotropic growth pattern of Leishmania tropica in BALB/c mice is suggestive of a murine model for human viscerotropic leishmaniasis.
    Mahmoudzadeh-Niknam H, Kiaei SS, Iravani D.
    Korean J Parasitol; 2007 Dec 15; 45(4):247-53. PubMed ID: 18165706
    [Abstract] [Full Text] [Related]

  • 9. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.
    Titus RG, Marchand M, Boon T, Louis JA.
    Parasite Immunol; 1985 Sep 15; 7(5):545-55. PubMed ID: 3877902
    [Abstract] [Full Text] [Related]

  • 10. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 11. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD, Heinzel FP, Shigekane VM, Fisher WL, Locksley RM.
    J Immunol; 1987 Aug 15; 139(4):1303-9. PubMed ID: 3112230
    [Abstract] [Full Text] [Related]

  • 12. Immunization of susceptible hosts with a soluble antigen fraction from Leishmania major leads to aggravation of murine leishmaniasis mediated by CD4+ T cells.
    Bogdan C, Schröppel K, Lohoff M, Röllinghoff M, Solbach W.
    Eur J Immunol; 1990 Dec 15; 20(12):2533-40. PubMed ID: 1980108
    [Abstract] [Full Text] [Related]

  • 13. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H, Scollay R.
    Eur J Immunol; 1989 Feb 15; 19(2):307-14. PubMed ID: 2467816
    [Abstract] [Full Text] [Related]

  • 14. Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.
    Bogdan C, Streck H, Röllinghoff M, Solbach W.
    Clin Exp Immunol; 1989 Jan 15; 75(1):141-6. PubMed ID: 2702771
    [Abstract] [Full Text] [Related]

  • 15. Cell contact-mediated macrophage activation for antileishmanial defense. II. Identification of effector cell phenotype and genetic restriction.
    Sypek JP, Panosian CB, Wyler DJ.
    J Immunol; 1984 Dec 15; 133(6):3351-7. PubMed ID: 6333458
    [Abstract] [Full Text] [Related]

  • 16. Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice.
    Rostamian M, Sohrabi S, Kavosifard H, Niknam HM.
    J Microbiol Immunol Infect; 2017 Apr 15; 50(2):160-166. PubMed ID: 26066544
    [Abstract] [Full Text] [Related]

  • 17. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 18. Production of tumour necrosis factor during murine cutaneous leishmaniasis.
    Moll H, Binöder K, Bogdan C, Solbach W, Röllinghoff M.
    Parasite Immunol; 1990 Sep 15; 12(5):483-94. PubMed ID: 2255560
    [Abstract] [Full Text] [Related]

  • 19. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells.
    Moll H, Fuchs H, Blank C, Röllinghoff M.
    Eur J Immunol; 1993 Jul 15; 23(7):1595-601. PubMed ID: 8325337
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.